Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-003223

President and CEO gave up 1,584 shares (to pay taxes)

  • President and CEO acquired 5,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2024-02-12 Grant or award +5,400 812,193 D
Luly Jay R. President and CEO 2024-02-12 Shares withheld for taxes −1,584 $12.41 $19,657 810,609 D
Loading xslF345X05/form4.xml…